138 related articles for article (PubMed ID: 19591288)
1. [Anti-aging medicine: the evidence to the value of the antihypertensive drugs, hypoglycemic drugs and statins].
Okumachi Y; Yokono K
Nihon Rinsho; 2009 Jul; 67(7):1372-6. PubMed ID: 19591288
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification for the prevention of cardiovascular complications of hypertension.
Girerd X; Giral P
Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
[TBL] [Abstract][Full Text] [Related]
3. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
Rosenson RS
Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions in the prevention of type 2 diabetes.
Henness S
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
[TBL] [Abstract][Full Text] [Related]
5. Statins in hypertension: are they a new class of antihypertensive agents?
Feldstein CA
Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
[TBL] [Abstract][Full Text] [Related]
6. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
Zarich SW
Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy for the treatment of diabetic dyslipidemia.
Haffner SM
Diabetes Metab Res Rev; 2003; 19(4):280-7. PubMed ID: 12879405
[TBL] [Abstract][Full Text] [Related]
8. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
9. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
Bösel J; Amiri H
Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
[TBL] [Abstract][Full Text] [Related]
10. The antihypertensive actions of statins: modulation by salt intake.
Juncos LI; Juncos LA; García NH
Am J Hypertens; 2012 Nov; 25(11):1140-8. PubMed ID: 22833031
[TBL] [Abstract][Full Text] [Related]
11. Statins and hypertension.
Pelat M; Balligand JL
Semin Vasc Med; 2004 Nov; 4(4):367-75. PubMed ID: 15861317
[TBL] [Abstract][Full Text] [Related]
12. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
13. [Examples of results of pharmaceutical cerebrovascular protection, with special emphasis on the statins].
Bajnok L
Ideggyogy Sz; 2011 Mar; 64(5-6):151-6. PubMed ID: 21692273
[TBL] [Abstract][Full Text] [Related]
14. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
15. Management of dyslipidemia in diabetes.
Solano MP; Goldberg RB
Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
[TBL] [Abstract][Full Text] [Related]
16. [Hypertension and hyperlipidemia].
Hansen HS; Larsen ML
Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
18. Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?
Correa V; Gus M; Fuchs FD
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):775-9. PubMed ID: 20528635
[TBL] [Abstract][Full Text] [Related]
19. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
